Stocktoria
DEXCOM INC DXCM
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2005-04-14
DEXCOM INC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $4.7B | $4.0B | $3.6B | $2.9B | $2.4B |
| Gross profit | $2.8B | $2.4B | $2.3B | $1.9B | $1.7B |
| R&D expense | $599.1M | $552.4M | $505.8M | $484.2M | $517.1M |
| SG&A expense | $1.3B | $1.3B | $1.2B | $1.0B | $810.5M |
| Operating income | $911.8M | $600.0M | $597.7M | $391.2M | $265.8M |
| Interest expense | — | — | $20.3M | $18.6M | $18.8M |
| Income tax | $252.1M | $132.8M | $168.9M | $49.6M | $39.9M |
| Net income | $836.3M | $576.2M | $541.5M | $341.2M | $216.9M |
| EPS (diluted) | $2.09 | $1.42 | $1.30 | $0.82 | $0.53 |
| Operating cash flow | $1.4B | $989.5M | $748.5M | $669.5M | $442.5M |
| Free cash flow | $1.1B | $630.7M | $511.9M | $304.7M | $53.3M |
| Cash & equivalents | $917.7M | $606.1M | $566.3M | $642.3M | $1.1B |
| Inventory | $629.1M | $542.6M | $559.6M | $306.7M | $357.3M |
| Total assets | $6.3B | $6.5B | $6.3B | $5.4B | $4.9B |
| Total liabilities | $3.6B | $4.4B | $4.2B | $3.3B | $2.9B |
| Shareholders' equity | $2.7B | $2.1B | $2.1B | $2.1B | $2.0B |
Source: SEC EDGAR filings · CIK 0001093557 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.